RAPT Therapeutics, Inc. (RAPT) Assets Average (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Assets Average for 5 consecutive years, with $117.8 million as the latest value for Q3 2024.
- Quarterly Assets Average fell 43.96% to $117.8 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $117.8 million through Sep 2024, down 43.96% year-over-year, with the annual reading at $219.8 million for FY2023, 5.44% down from the prior year.
- Assets Average hit $117.8 million in Q3 2024 for RAPT Therapeutics, down from $141.5 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $257.3 million in Q1 2023 to a low of $112.4 million in Q1 2021.
- Historically, Assets Average has averaged $182.3 million across 5 years, with a median of $189.8 million in 2022.
- Biggest five-year swings in Assets Average: soared 71.72% in 2022 and later tumbled 43.96% in 2024.
- Year by year, Assets Average stood at $124.0 million in 2020, then soared by 67.82% to $208.0 million in 2021, then grew by 14.32% to $237.8 million in 2022, then fell by 21.58% to $186.5 million in 2023, then tumbled by 36.83% to $117.8 million in 2024.
- Business Quant data shows Assets Average for RAPT at $117.8 million in Q3 2024, $141.5 million in Q2 2024, and $164.6 million in Q1 2024.